Affordable Access

deepdyve-link
Publisher Website

The path(way) less traveled.

Authors
Type
Published Article
Journal
Blood
Publisher
American Society of Hematology
Volume
122
Issue
12
Pages
1996–1996
Identifiers
DOI: 10.1182/blood-2013-07-516856
Source
Murphy Lab dermatology-ucdavis
License
Unknown

Abstract

In this issue of Blood, Mathewson et al characterized targeting a novel intracellular pathway with an agent known to induce potent antitumor effects but now also appears to potently suppress inflammatory responses by dendritic cells (DCs) and prevent graft-vs-host disease (GVHD). Identifying agents that can suppress GVHD yet not compromise graft-vs-tumor (GVT) effects remains a paramount goal in allogeneic hematopoietic stem cell transplantation (HSCT).

Report this publication

Statistics

Seen <100 times